| Term 
 | Definition 
 
        | used to reduce number and severity of seizures with epilepsy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | recurrent paroxysmal disorder of brain function sudden attacks of altered consciousness, motor activity, sensory impairment
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Generalized seizures:  bilaterally symmetrical without local onset Partial seizures:  complex symptomatology, temporal lobe or psychomotor
 Unclassified:  insufficient data to classify
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Grand Mal/ Tonic-clonic absence
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | loss of consciousness, falling generalized tonic, followed by clonic contraction 2-5 minutes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | continuous tonic/clonic seizures IV diazepam, IV phenytoin
 |  | 
        |  | 
        
        | Term 
 
        | Absence epilepsy Petit Mal
 |  | Definition 
 
        | absence of convulsions ethosuximide/Zarontin if ineffective clonazepam/Klonopin and Valproic acid/Depakane
 |  | 
        |  | 
        
        | Term 
 
        | Absence drug side effects |  | Definition 
 
        | sedation, dizziness, irritability GI
 Caution:  hepatic, renal, preg/lac, pancreatitis (valproate)
 |  | 
        |  | 
        
        | Term 
 
        | Psychomotor epilepsy aka temporal lobe seizures |  | Definition 
 
        | aka partial seizures with complex symptomology lesion in left lobe of brain
 complex symptoms:  confusion, staggering, purposeless movements, bizarre behavior, unintelligible sounds
 no convulsions
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prophylactic treatment for Grand Mal and Psychomotor combined with phenobarbital or valproic acid
 |  | 
        |  | 
        
        | Term 
 
        | phenytoin/Dilantin side effects |  | Definition 
 
        | sedation, ataxia, dizziness, ha blurred vision, nystagmus, diplopia
 gingivitis
 GI anorexia, constip, diarr
 |  | 
        |  | 
        
        | Term 
 
        | phenytoin/Dilantin contraindications and cautions |  | Definition 
 
        | kidney, liver diabetes
 CHF, bradycardia, heart block, hypotension
 preg/lac
 hematological dis
 abrupt disc.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sometimes used for partial, generalized or mixed seizures |  | 
        |  | 
        
        | Term 
 
        | carbamazepine/Tegretol side effects |  | Definition 
 
        | cardiac, hematological, kidney, liver, complications grapefruit juice potentiates actions, serious side effects
 |  | 
        |  | 
        
        | Term 
 
        | new formulations anticonvulsants |  | Definition 
 
        | Tegretol XR, Diastat, fosphenytoin/Cerebyx - IM, IV, valproate/Depacon - IV, Depakote ER |  | 
        |  | 
        
        | Term 
 
        | 2nd generation anticonvulsants |  | Definition 
 
        | gabapentin/Neurontin lamotrigine/Lamictal
 topiramate/Topamax
 \adjuvant treatment of partial psychomotor seizures, no lab monitoring, fewer cognitive effects
 slow titration\
 not in preg
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | psychomotor, partial or mixed seizures first generation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | absence seizures first generation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | first generation grand mal, psychomotor, focal
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | absence seizures first generation
 |  | 
        |  | 
        
        | Term 
 
        | valproic acid/Depakene, Depakote, Depacon |  | Definition 
 
        | first generation absence, partial, tonic-clonic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | partial seizures, minimal drug interactions, decrease with renal dysfunc second generation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | second generation partial seizures, monitor liver function
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | partial seizures, may effect cognitive function second generation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chronic neurological disorder, fine, slowly spreading tremors, rigidity, weakness of muscles, shuffling advanced:  dementia, confusion, psychosis, sleep disturb, declining cognitive function
 |  | 
        |  | 
        
        | Term 
 
        | Levadopa and Carbidopa/Sinemet |  | Definition 
 
        | crosses blood-brain barrier, increases therapeutic effect of dopamine long term, over 70, dementia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dyskinesias NV anorexia
 behavioral, anxiety, agitation, confusionn, depression, psychosis
 hypotension dizziness, syncope
 |  | 
        |  | 
        
        | Term 
 
        | Levadopa and Carbidopa/Sinemet contraindications |  | Definition 
 
        | abrupt discontinuance bronchial asthma or emphysema
 cardiac or hypotension
 peptic ulcer
 diabetes, renal, hepatic
 glaucoma
 psychoses
 preg, pp, lac
 |  | 
        |  | 
        
        | Term 
 
        | Levadopa and Carbidopa/Sinemet interactions |  | Definition 
 
        | antihypertensives potentiate hypotension phenytoin antagonizes levodopa
 iron salts
 high protein reduce absorp
 MAOI's hypertensive crisis
 |  | 
        |  | 
        
        | Term 
 
        | selegilene, entacapone, dopamine agonist |  | Definition 
 
        | help when tolerance to Sinemet as well as changing dosage time, controlled releawse |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used with levodopa to delay motor complications bromocriptine/Parlodel, not used alone, many side effects
 pramipexole/Mirapex
 ropinirole/Requip
 antiparkinsonian
 |  | 
        |  | 
        
        | Term 
 
        | pramipexole/Mirapex and ropinirole/Requip |  | Definition 
 
        | initial monotherapy less than 70 yo greater specificity for dopamine receptors
 neuroprotective, less dyskinesia
 antiparkinsonian
 |  | 
        |  | 
        
        | Term 
 
        | dopamine agonist side effects |  | Definition 
 
        | psychosis, hallucinations, confusion, somnolence hypotension, syncope
 N & V
 |  | 
        |  | 
        
        | Term 
 
        | dopamine agonist contraindications |  | Definition 
 
        | antidopamine agents:  antipsychotics, phenothiazines, metoclopramide decrease efficiency hypnotic and sedative can potentiate somnolence
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAO type B inhibitor used with levodopa when wearing off, levodopa dosage decreased 10-20%
 not given alone
 antiparkinsonian
 |  | 
        |  | 
        
        | Term 
 
        | selegiline/Eldepryl contraindications |  | Definition 
 
        | ok with food at 10mg divided dosages CNS toxicity:  meperidine/Demerol, tricyclic antidepressants, SSRI's, sympathomimetics, epinephrine, ephedrine, isoproterenol
 abrupt discontinuation
 antiparkinsonian
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | treat Parkinsonism extrapyraminal reactions due to use of phenothiazines, carbon minoxide poisoning, cerebral arteriosclerosis in older antiparkinsonian
 viral upper respiratory\
 drug induced parkinsonism
 |  | 
        |  | 
        
        | Term 
 
        | amantadine/Symmetrel side effects |  | Definition 
 
        | CNS disturb:  depression, confusion, hallucinations, anxiety, irritability, nervousness, dizziness Congestive heart failure, edema, hypotension
 GI distress, constipation, urinary retention
 |  | 
        |  | 
        
        | Term 
 
        | amantadine/Symmetrel contraindications |  | Definition 
 
        | liver, kidney, cardiac psychosis, neurosis, mental depression
 epilepsy
 antiparkinsonian
 CNS drugs
 |  | 
        |  | 
        
        | Term 
 
        | COMT inhibitors/catechol-O-methyl-transferase |  | Definition 
 
        | entacapone/Comtan block enzyme that metabolizes levodopa, enhances amount of levodopa across barrier
 lower dose
 increases on time of levodopa, decreases off time
 antiparkinsonian
 |  | 
        |  | 
        
        | Term 
 
        | entacapone/Comtan (COMT inhibitor) side effects |  | Definition 
 
        | No nonselective MAOI's, phenelzine or tranylcypromine, selective (selegiline)ok orthostatic hypotension
 hallucinaqtions
 dyskinesia
 diarrhea
 orange urine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | devastating progressive decline in cognitive function, gradual onset between 60-90 yo severe impairment of social and occupational functioning
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alzheimers prevent breakdown of acetylcholine in synaptic cleft
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st approved drug for Alzheimer's hepatotoxicity, frequent dosing schedule
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | with or without food cholinase inhibitor/Alzheimers
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinase inhibitor/Alzheimers increase to 3-6 mg bid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinase inhibitor monitor serum transaminase levels
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | caution renal/hepatic cholinase inhibitor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | N-methyl-D-aspartate antagonist monotherapy or combo with donepezil/Aricept
 CNS side effects, esp agitation
 |  | 
        |  | 
        
        | Term 
 
        | NMDA receptor agonist N-methyl-D-aspartate
 |  | Definition 
 
        | moderate to severe dementia selectively block excitotoxic effects with abnormal transmission of glutamate/allows with normal function
 used with donepezil/Aricept
 also earlier stages of Alzheimers
 |  | 
        |  | 
        
        | Term 
 
        | NMDA/N-methyl-D-aspartate side effects |  | Definition 
 
        | CNS, dose dependent confusion, cerebrovascular disorder, falls and agitation
 dizziness, headache, constipation
 |  | 
        |  | 
        
        | Term 
 
        | NMDA/N-methyl-D-aspartate contraindications |  | Definition 
 
        | preg/lac, children, renal disease interacts with NMDA antagonists:amantadine, ketamine, dextromethorphan
 |  | 
        |  |